Sprue-Like histology in patients with abdominal pain taking olmesartan compared with other angiotensin receptor blockers

Journal of Clinical Pathology

Volumn 68, Issue 1, 2015, Pages 29-32

  Lagana, Stephen M ^a   Braunstein, Eric D ^a   Arguelles Grande, Carolina ^a   Bhagat, Govind ^a   Green, Peter H R ^a   Lebwohl, Benjamin ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; IRBESARTAN; LOSARTAN; OLMESARTAN; TELMISARTAN; VALSARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; COHORT ANALYSIS; DUODENUM BIOPSY; ENTEROPATHY; EOSINOPHILIA; FEMALE; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE VILLUS ATROPHY; MALE; NEUTROPHILIA; RETROSPECTIVE STUDY; UNSPECIFIED SIDE EFFECT; CELIAC DISEASE; CHEMICALLY INDUCED; COMPARATIVE STUDY; MIDDLE AGED;

ABDOMINAL PAIN; ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CELIAC DISEASE; COHORT STUDIES; FEMALE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TETRAZOLES;

EID: 84919341685     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2014-202615     Document Type: Article

References (18)

1. Rubio-Tapia A, Herman ML, Ludvigsson JF, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 2012;87:732-8
2. DeGaetani M, Tennyson CA, Lebwohl B, et al. Villous atrophy and negative celiac serology: A diagnostic and therapeutic dilemma. Am J Gastroenterol. 2013;108:647-53
3. Abdelghany M, Gonzalez L 3rd, Slater J, et al. Olmesartan associated sprue-like enteropathy and colon perforation. Case Rep Gastrointest Med 2014;2014:494098
4. de Fonseka A, Tuskey A, Moskaluk C. A case of olmesartan induced enteropathy. Inflamm Bowel Dis 2012;18(Suppl 17)
5. Dreifuss SE, Tomizawa Y, Farber NJ, et al. Spruelike enteropathy associated with olmesartan: An unusual case of severe diarrhea. Case Rep Gastrointest Med 2013;2013:618071
6. Fiorucci G, Puxeddu E, Colella R, et al. Severe spruelike enteropathy due to olmesartan. Rev Esp Enferm Dig 2014;106:142-4
7. Gaur V, Albeldawi M, Weber L. Chronic diarrhea and weight loss. Gastroenterology 2014;146:347,591
8. Ianiro G, Bibbo S, Montalto M, et al. Systematic review: sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther. 2014;40:16-23
9. Khan AS, Peter S, Wilcox CM. Olmesartan-induced enteropathy resembling celiac disease. Endoscopy 2014;46(Suppl 1 UCTN):E97-8
10. Nielsen JA, Steephen A, Lewin M. Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug. World J Gastroenterol 2013;19:6928-30
11. Stanich PP, Yearsley M, Meyer MM. Olmesartan-associated sprue-like enteropathy. J Clin Gastroenterol. 2013;47:894-5
12. Theophile H, David XR, Miremont-Salame G, et al. Five cases of sprue-like enteropathy in patients treated by olmesartan. Dig Liver Dis 2014;46:465-9
13. Greywoode R, Braunstein ED, Arguelles-Grande C, et al. Olmesartan, other antihypertensives, and chronic diarrhea among patients undergoing endoscopic procedures: A case-control study. Mayo Clin Proc. 2014;89:1239-43
14. Shmidt E, Smyrk TC, Boswell CL, et al. Increasing duodenal intraepithelial lymphocytosis found at upper endoscopy: time trends and associations. Gastrointest Endosc. 2014;80:105-11
15. Kakar S, Nehra V, Murray JA, et al. Significance of intraepithelial lymphocytosis in small bowel biopsy samples with normal mucosal architecture. Am J Gastroenterol. 2003;98:2027-33
16. Talbot GH. Small bowel histopathologic findings suggestive of celiac disease in an asymptomatic patient receiving olmesartan. Mayo Clin Proc. 2012;87:1231-2; author reply 2
17. Herman M, Rubio-Tapia A, Marietta E, et al. Severe Enteropathy in a Patient on Valsartan. Am J Gastroenterol 2013;108(Suppl1):S302
18. Parfitt JR, Jayakumar S, Driman DK. Mycophenolate mofetil-related gastrointestinal mucosal injury: Variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol. 2008;32:1367-72.